way 100135 has been researched along with cyanopindolol in 1 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (cyanopindolol) | Trials (cyanopindolol) | Recent Studies (post-2010) (cyanopindolol) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 247 | 1 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chojnacka-Wójcik, E; Przegalinski, E; Tatarczyńska, E | 1 |
1 other study(ies) available for way 100135 and cyanopindolol
| Article | Year |
|---|---|
The role of hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Hippocampus; Male; Pindolol; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1995 |